2m 2m 2m 2m 2m 2m 2m
NUVATION BIO-A (NUVB)
NYSE
$6.08+$0.006 (+0.10%)
Price as of Sep 11, 2026 7:54 PM EDT- $2.1BMarket Cap
- 93.31%1-Year Change
- BiotechnologyIndustry
NUVATION BIO-A (NUVB)
$6.08+$0.006 (+0.10%)
NUVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.07 | ||
Change | -$0.21 (-3.34%) | ||
Open | $6.36 | ||
High | $6.39 | ||
Low | $5.95 | ||
Previous Close | $6.28 | ||
Volume | 4,318,563 | ||
30-Day Average Volume | 5,215,690 | ||
1-Week Change | -10.87% | ||
1-Month Change | -4.71% | ||
1-Year Change | 93.31% | ||
3-Year Change | 294.16% | ||
5-Year Change | -35.01% | ||
Fundamentals | |||
Shares Outstanding | 350.1M | ||
Total Assets | $744.5M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $23.2M | ||
Net Income | -$62.8M | ||
Free Cash Flow | -$43.2M | ||
EBIT | -$57.7M | ||
EBITDA | -$57.2M | ||
Net Working Capital | $639.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | 91 | ||
P/B | 8 | ||
P/E | -34 | ||
PEG | 0 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue